tyloxapol has been researched along with Chronic Lung Injury in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Fang, F; He, J; Li, N; Lu, Y; Talbi, A; Tang, Y; Zhang, G; Zhang, Y; Zheng, J; Zhu, J | 1 |
1 other study(ies) available for tyloxapol and Chronic Lung Injury
| Article | Year |
|---|---|
Effect of pulmonary surfactant and phospholipid hexadecanol tyloxapol on recombinant human-insulin absorption from intratracheally administered dry powders in diabetic rats.
Topics: Absorption; Acetylglucosaminidase; Alkaline Phosphatase; Animals; Blood Glucose; Chemistry, Pharmaceutical; Diabetes Mellitus, Experimental; Drug Administration Routes; Humans; Hydro-Lyases; Hypoglycemic Agents; Insulin; Lung Injury; Phospholipids; Polyethylene Glycols; Powders; Pulmonary Surfactants; Rats; Recombinant Proteins; Surface-Active Agents; Time Factors; Trachea | 2010 |